Pfizer Inc. logo
Pfizer Inc. (PFE)
Compare

Pfizer Inc. (PFE) Free Cash Flow Yield: 6.35%

popular:market cap|pe ratio|revenue|price history|total return

Is Pfizer Inc.’s free cash flow yield high or low?

Pfizer Inc.'s free cash flow yield of 6.35% is 14% below its 5-year average of 7.34%, around the middle of its 5-year range (2.80%–11.93%).

As of Wednesday, June 17, 2026. 13.33% below its 12-month average of 7.33%.

Free Cash Flow CAGR|Earnings Yield|Dividend Yield|P/FCF Ratio|All Metrics

PFE Free Cash Flow Yield Chart

PFE Free Cash Flow Yield
6.35%-21.12% 1Y
Zoom

PFE Average Free Cash Flow Yield Chart

PFE Current vs Average Free Cash Flow Yield Chart

PFE Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

6.35%

FREE CASH FLOW YIELD AVG TTM

7.33%

FREE CASH FLOW YIELD AVG 3Y

5.91%

FREE CASH FLOW YIELD AVG 5Y

7.34%

FREE CASH FLOW YIELD AVG 10Y

6.47%

FREE CASH FLOW YIELD AVG 15Y

7.25%

FREE CASH FLOW YIELD AVG 20Y

7.54%

CURRENT VS TTM AVG

-13.33%

CURRENT VS 3Y AVG

+7.35%

CURRENT VS 5Y AVG

-13.51%

CURRENT VS 10Y AVG

-1.90%

CURRENT VS 15Y AVG

-12.46%

CURRENT VS 20Y AVG

-15.81%

PFE Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Pfizer Inc. (PFE)$148.41B6.35%7.33%5.91%7.34%
Intuitive Surgical, Inc. (ISRG)vs ›$145.70B1.89%1.30%0.87%1.09%
Abbott Laboratories (ABT)vs ›$157.84B4.66%3.50%3.07%3.51%
Gilead Sciences, Inc. (GILD)vs ›$158.06B6.41%6.07%7.44%8.68%
Danaher Corporation (DHR)vs ›$128.06B4.10%3.50%3.47%3.67%
CVS Health Corporation (CVS)vs ›$127.73B5.74%6.51%9.17%10.64%
Thermo Fisher Scientific Inc. (TMO)vs ›$175.64B3.83%3.34%3.40%3.32%
Stryker Corporation (SYK)vs ›$115.45B3.93%2.99%2.49%2.53%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$115.02B3.19%3.06%3.41%3.84%
Bristol-Myers Squibb Company (BMY)vs ›$114.19B10.42%13.27%12.28%10.97%

Yield Comparison

FCF Yield

6.35%

Earnings Yield

5.03%

Dividend Yield

6.61%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Pfizer Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Pfizer Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for Pfizer Inc. (PFE)?
The free cash flow yield for PFE stock is 6.35%.
Is Pfizer Inc.'s free cash flow yield high or low?
Pfizer Inc.'s free cash flow yield of 6.35% is 14% below its 5-year average of 7.34%, around the middle of its 5-year range (2.80%–11.93%).
What is the TTM average free cash flow yield for Pfizer Inc. (PFE)?
The TTM average free cash flow yield for PFE stock is 7.33%.
What is the 3Y average free cash flow yield for Pfizer Inc. (PFE)?
The 3Y average free cash flow yield for PFE stock is 5.91%.
What is the 5Y average free cash flow yield for Pfizer Inc. (PFE)?
The 5Y average free cash flow yield for PFE stock is 7.34%.
What is the 10Y average free cash flow yield for Pfizer Inc. (PFE)?
The 10Y average free cash flow yield for PFE stock is 6.47%.
What is the 15Y average free cash flow yield for Pfizer Inc. (PFE)?
The 15Y average free cash flow yield for PFE stock is 7.25%.
What is the 20Y average free cash flow yield for Pfizer Inc. (PFE)?
The 20Y average free cash flow yield for PFE stock is 7.54%.

Pfizer Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-166.35%
2026-06-156.37%
2026-06-126.31%
2026-06-116.33%
2026-06-106.46%
2026-06-096.44%
2026-06-086.46%
2026-06-056.35%
2026-06-046.44%
2026-06-036.53%
2026-06-026.48%
2026-06-016.46%
2026-05-296.32%
2026-05-286.33%
2026-05-276.31%
2026-05-266.40%
2026-05-226.39%
2026-05-216.38%
2026-05-206.42%
2026-05-196.45%
2026-05-186.53%
2026-05-156.53%
2026-05-146.43%
2026-05-136.37%
2026-05-126.40%
2026-05-116.41%
2026-05-086.44%
2026-05-076.25%
2026-05-066.24%
2026-05-056.26%
2026-05-046.07%
2026-05-016.06%
2026-04-305.98%
2026-04-296.08%
2026-04-286.03%
2026-04-275.96%
2026-04-245.91%
2026-04-235.98%
2026-04-225.96%
2026-04-215.84%
2026-04-205.80%
2026-04-175.79%
2026-04-165.87%
2026-04-155.87%
2026-04-145.89%
2026-04-135.84%
2026-04-105.93%
2026-04-095.87%
2026-04-085.81%
2026-04-075.89%
2026-04-065.73%
2026-04-025.64%
2026-04-015.59%
2026-03-315.69%
2026-03-305.75%
2026-03-275.90%
2026-03-265.79%
2026-03-255.85%
2026-03-245.92%
2026-03-235.96%
2026-03-205.92%
2026-03-195.82%
2026-03-185.84%
2026-03-175.81%
2026-03-166.00%
2026-03-136.01%
2026-03-125.94%
2026-03-115.85%
2026-03-105.88%
2026-03-095.95%
2026-03-065.90%
2026-03-056.00%
2026-03-046.00%
2026-03-036.01%
2026-03-025.85%
2026-02-275.77%
2026-02-265.89%
2026-02-256.70%
2026-02-246.69%
2026-02-236.71%
2026-02-206.81%
2026-02-196.76%
2026-02-186.64%
2026-02-176.64%
2026-02-136.58%
2026-02-126.61%
2026-02-116.55%
2026-02-106.58%
2026-02-096.71%
2026-02-066.67%
2026-02-056.85%
2026-02-046.78%
2026-02-037.05%
2026-02-026.81%
2026-01-306.87%
2026-01-296.96%
2026-01-287.02%
2026-01-276.85%
2026-01-267.02%
2026-01-237.08%
2026-01-226.96%
2026-01-217.01%
2026-01-207.12%
2026-01-167.08%
2026-01-157.01%
2026-01-147.10%
2026-01-137.22%
2026-01-127.18%
2026-01-097.13%
2026-01-087.18%
2026-01-077.18%
2026-01-067.14%
2026-01-057.22%
2026-01-027.21%
2025-12-317.29%
2025-12-307.27%
2025-12-297.26%
2025-12-267.24%
2025-12-247.26%
2025-12-237.30%
2025-12-227.20%
2025-12-197.21%
2025-12-187.25%
2025-12-177.25%
2025-12-167.11%
2025-12-156.87%
2025-12-127.02%
2025-12-117.04%
2025-12-107.04%
2025-12-097.17%
2025-12-087.05%
2025-12-056.98%
2025-12-047.07%
2025-12-037.10%
2025-12-027.22%
2025-12-017.18%
2025-11-287.06%
2025-11-267.06%
2025-11-257.06%
2025-11-247.20%
2025-11-217.25%
2025-11-207.44%
2025-11-197.30%
2025-11-187.13%
2025-11-177.24%
2025-11-147.25%
2025-11-137.04%
2025-11-127.02%
2025-11-117.12%
2025-11-107.45%
2025-11-077.43%
2025-11-067.31%
2025-11-057.38%
2025-11-047.47%
2025-11-038.84%
2025-10-318.84%
2025-10-308.98%
2025-10-298.98%
2025-10-288.90%
2025-10-278.80%
2025-10-248.80%
2025-10-238.83%
2025-10-228.82%
2025-10-218.77%
2025-10-208.83%
2025-10-178.90%
2025-10-168.99%
2025-10-158.94%
2025-10-148.89%
2025-10-138.81%
2025-10-108.80%
2025-10-098.64%
2025-10-088.49%
2025-10-078.30%
2025-10-068.25%
2025-10-037.96%
2025-10-028.05%
2025-10-018.01%
2025-09-308.55%
2025-09-299.14%
2025-09-269.17%
2025-09-259.23%
2025-09-249.05%
2025-09-239.03%
2025-09-229.07%
2025-09-199.07%
2025-09-189.03%
2025-09-179.07%
2025-09-169.12%
2025-09-159.09%
2025-09-129.13%
2025-09-118.77%
2025-09-108.87%
2025-09-098.82%
2025-09-088.88%
2025-09-058.76%
2025-09-048.88%
2025-09-038.80%
2025-09-028.73%
2025-08-298.80%
2025-08-288.86%
2025-08-278.70%
2025-08-268.75%
2025-08-258.67%
2025-08-228.42%
2025-08-218.47%
2025-08-208.59%
2025-08-198.61%
2025-08-188.70%
2025-08-158.67%
2025-08-148.68%
2025-08-138.67%
2025-08-128.84%
2025-08-118.87%
2025-08-088.87%
2025-08-078.99%
2025-08-069.11%
2025-08-058.81%
2025-08-048.35%
2025-08-018.37%
2025-07-318.44%
2025-07-308.25%
2025-07-298.08%
2025-07-288.08%
2025-07-257.92%
2025-07-247.75%
2025-07-237.75%
2025-07-227.82%
2025-07-218.10%
2025-07-188.03%
2025-07-177.99%
2025-07-167.99%
2025-07-157.99%
2025-07-147.75%
2025-07-117.66%
2025-07-107.62%
2025-07-097.69%
2025-07-087.67%
2025-07-077.79%
2025-07-037.74%
2025-07-027.76%
2025-07-017.85%
2025-06-308.10%
2025-06-278.12%
2025-06-268.10%
2025-06-258.10%
2025-06-248.08%
2025-06-238.18%
2025-06-208.20%
2025-06-188.23%
2025-06-178.19%
2025-06-168.05%
2025-06-138.01%
2025-06-127.91%
2025-06-118.03%
2025-06-108.08%
2025-06-098.20%
2025-06-068.42%
2025-06-058.50%
2025-06-048.40%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

Related Metrics

Free Cash Flow CAGREarnings YieldDividend YieldP/FCF RatioAll Metrics

About Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.

New York City, NY
81,000 employees
www.pfizer.com
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Albert Bourla
View full financials